Mogadon 5mg Nitrazepam Tablets

Mogadon 5mg Nitrazepam is a prescription-only benzodiazepine medicine containing 5mg of nitrazepam in each tablet. Nitrazepam acts on the central nervous system and has sedative effects that can reduce alertness and promote sleep.

Mogadon is intended for the short-term treatment of insomnia when sleeping difficulties are severe, disabling or causing significant distress. Because benzodiazepines can cause tolerance, dependence and withdrawal symptoms, treatment should be supervised by an appropriate healthcare professional.

What Is Mogadon 5mg Nitrazepam?

Mogadon is a brand of medicine containing the active ingredient nitrazepam. Nitrazepam belongs to the benzodiazepine group of medicines.

Each Mogadon tablet contains 5mg of nitrazepam. The official product information describes Mogadon as a prescription-only medicine intended for short-term use in severe insomnia.

Benzodiazepines can cause sedation, drowsiness and reduced alertness. Because these effects may continue after waking, patients should understand how the medicine affects them before driving or carrying out activities that require concentration and coordination.

For additional sleep-related information, see our Sleeping Pills section.

What Is Mogadon Used For?

Mogadon 5mg Nitrazepam is indicated for the short-term treatment of severe insomnia where daytime sedation is considered acceptable.

Insomnia can involve difficulty falling asleep, waking repeatedly during the night or experiencing sleep that does not provide adequate rest. However, benzodiazepines are not intended to be a routine long-term solution for sleeping problems.

A healthcare professional should assess possible underlying causes of insomnia before treatment and determine whether nitrazepam is appropriate for the individual patient.

How Should Mogadon Be Used?

Mogadon should only be taken according to the instructions provided by the prescribing healthcare professional.

Patients should not increase the amount taken, use additional tablets or extend treatment beyond the prescribed period. The official product information recommends keeping treatment as short as clinically appropriate.

Mogadon should also not normally be stopped suddenly following regular use. Abrupt discontinuation can lead to withdrawal symptoms or a temporary return of insomnia in a more pronounced form. A healthcare professional may recommend gradually reducing treatment when discontinuation is appropriate.

For detailed prescribing information, consult the official Mogadon 5mg Summary of Product Characteristics.

Mogadon 5mg Nitrazepam Safety Information

Mogadon can cause sedation, reduced alertness, dizziness and impaired coordination. These effects can increase the risk associated with driving, operating machinery or performing other activities requiring concentration.

Alcohol should be avoided because it can increase the central nervous system effects of nitrazepam.

Particular caution is required when benzodiazepines are combined with opioids or other medicines that depress the central nervous system. Such combinations can increase the risk of severe sedation and respiratory depression.

Mogadon may not be appropriate for patients with certain conditions, including severe respiratory insufficiency, sleep apnoea syndrome, severe hepatic insufficiency or myasthenia gravis. The official product information also states that Mogadon tablets are contraindicated for use in children.

Patients should therefore provide their healthcare professional with a complete medical history and details of prescription medicines, over-the-counter products and other substances they use.

Dependence, Tolerance and Withdrawal

Nitrazepam can cause physical dependence and addiction. These risks can occur even when benzodiazepines are taken at recommended therapeutic doses, although the risk can increase with prolonged treatment.

Some patients may also develop tolerance, meaning the effects of the medicine can become less noticeable after repeated use. Patients should never increase their dose themselves if they believe treatment has become less effective.

Withdrawal symptoms can occur when treatment is stopped abruptly or reduced too quickly. Any decision to discontinue Mogadon 5mg Nitrazepam should therefore be discussed with the prescribing healthcare professional.

Possible Side Effects

Like other medicines, Mogadon can cause side effects. Reported effects can include:

• Drowsiness
• Reduced alertness
• Headache
• Dizziness
• Coordination or balance problems
• Muscle weakness
• Memory impairment
• Confusion
• Unusual behavioural or psychological reactions

Older or debilitated patients may be particularly sensitive to the effects of medicines that depress the central nervous system and may have an increased risk of falls.

Patients experiencing severe, persistent or unexpected symptoms should seek appropriate medical advice.

Patient Information and Precautions

Mogadon is prescribed for an individual patient and should not be shared with another person.

Before using the medicine, patients should read the supplied Patient Information Leaflet and discuss any concerns about interactions, pregnancy, medical conditions, dependence or withdrawal with their doctor or pharmacist.

The official Mogadon 5mg Patient Information Leaflet provides additional manufacturer-approved information about the medicine.

Mogadon 5mg Nitrazepam should always be used according to professional medical instructions and only for the period considered appropriate by the prescriber.